Skip to Content

ValueTheMarkets Podcast 033 – with Ray Barlow, CEO of E-Therapeutics (ETX)

Today’s guest on the ValueTheMarkets podcast is Dr Ray Barlow, CEO of E-Therapeutics (LSE:ETX). The company is employing a computer-based approach to the discovery of new drugs. It’s Network-Driven Discovery (NDD) platform employs techniques such as machine learning, artificial intelligence, and data analysis to find better drug solutions in a more efficient manner.

In the interview, Ray discusses the NDD platform, the company’s business model, the changes he’s made since joining the board in 2017, and talks about his background in the industry.

Valuethemarkets.com and Dynamic Investor Relations Ltd are not responsible for the content or accuracy of this article.  News and research are not recommendations to deal, and investments may fall in value so that you could lose some or all of your investment. Past performance is not an indicator of future performance.

  • Stuart Langelaan does not hold any position in the stock(s) and/or financial instrument(s) mentioned in the piece.
  • Stuart Langelaan has been paid to produce this piece by the company or companies mentioned above.
  • Dynamic Investor Relations Ltd, the owner of ValueTheMarkets.com, has been paid for the production this piece by the company or companies mentioned above.

Related Articles

Headlines

teathers app screenshot

App Empowering Private Investors

Crowd Equity for Placings, IPOs and Live Market Blockbuilds, designed to give provate investors access to placements and Intial Public Offerings (IPOs), predominantly on the London Stock Exchange’s Alternative Investment Market (AIM).